brentuximab,doxorubicin hydrochloride,dacarbazine,filgrastim,pegfilgrastim,nivolumab,vinblastine sulfate
seagen,amgen,bms
['nivo', 's1826']
excited to see results of s1826 presented at plenary by alex herrera, phenomenal mentor, teacher, and colleague. 1 year pfs 94% vs 86% in n-avd vs bv-avd, low rates of iraes, more neuropathy in bv arm, more neutropenia in nivo arm but no increased infectious toxicity!
Assistant Professor @cityofhope| interested in lymphoma and immune therapies